TRIFERIC AVNU FERRIC PYROPHOSPHATE CITRATE INJECTION

Serial Number 88904613
Registration 6456960
700

Registration Progress

Application Filed
May 7, 2020
Under Examination
Jun 8, 2021
Approved for Publication
Apr 13, 2021
Published for Opposition
Apr 13, 2021
Registered
Aug 17, 2021

Trademark Image

TRIFERIC AVNU FERRIC PYROPHOSPHATE CITRATE INJECTION

Basic Information

Serial Number
88904613
Registration Number
6456960
Filing Date
May 7, 2020
Registration Date
August 17, 2021
Published for Opposition
April 13, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 17, 2021
Registration
Registered
Classes
005

Rights Holder

ROCKWELL MEDICAL, INC.

03
Address
30142 Wixom Road
Wixom, MI 48393

Ownership History

ROCKWELL MEDICAL, INC.

Original Applicant
03
Wixom, MI

ROCKWELL MEDICAL, INC.

Owner at Publication
03
Wixom, MI

ROCKWELL MEDICAL, INC.

Original Registrant
03
Wixom, MI

Legal Representation

Attorney
MATTHEW J. GIPSON

USPTO Deadlines

Next Deadline
592 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210817)
Due Date
August 17, 2027
Grace Period Ends
February 17, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Aug 17, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 15, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 14, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 23, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 9, 2021 IUAF S USE AMENDMENT FILED Loading...
Jun 21, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 9, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 8, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 13, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 13, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 11, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 11, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 11, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 11, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 11, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 10, 2021 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Feb 23, 2021 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Feb 4, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 4, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 4, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 4, 2021 ALIE A ASSIGNED TO LIE Loading...
Oct 28, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 6, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 6, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 6, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 1, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 20, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 19, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 11, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
preparations for use in clinical and medical dialysis procedures; pharmaceutical solutions used in dialysis and hemodialysis; pharmaceutical preparations, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; pharmaceutical preparations for injection, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; iron delivery therapy, namely, commercial iron nutritional supplements, intravenous fluids used for the delivery of iron and soluble ferric pyrophosphate; all goods containing ferric pyrophosphate citrate
First Use Anywhere: Feb 10, 2021
First Use in Commerce: Feb 10, 2021

Additional Information

Design Mark
The mark consists of the words "TRIFERIC AVNU" in red capital letters above the words "ferric pyrophosphate citrate injection" in smaller, lower case gray letters. To the right of the literal element is a modified triangle shape, the inner field comprised of red and burgundy squares, with the smallest squares in blue.
Color Claim
The color(s) burgundy, red, blue and gray is/are claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"FERRIC PYROPHOSPHATE CITRATE INJECTION"